LU B 22 (Fenofibrate 145 mg)

Pill imprint LU B 22 has been identified as Fenofibrate 145 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fenofibrate

Imprint:

LU B 22

Strength:

145 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fibric acid derivatives

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Lupin Pharmaceuticals, Inc.

National Drug Code (NDC):

68180-0361

Inactive Ingredients:

crospovidone
hypromellose 2910 (3 mPa.s)
lactose monohydrate
magnesium stearate
polacrilin potassium
polyethylene glycol
polyvinyl alcohol
silicon dioxide
sodium lauryl sulfate
sucrose
magnesium silicate
titanium dioxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
68084-0636	Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.